Tag Archives: pharmaceutical industry
Health Reform Hazards: Steering Your Course Through the Rhetorical Shallows
Image by Getty Images via Dayli
Crafting consensus legislation on health reform depends heavily on all parties understanding precisely the terms of the debate. With the two House and Senate bills now topping out at more than 4,000 text pages, prospects for even a basic awareness of the implications of this reform for big pharma and [...]
Posted in FDA, News Also tagged Congress, Health, Health care, Insurance, Pharmaceutical drug, United States, United States Congress Leave a comment
Transformational Analytics Will Set You Free
Guest blog by W Scott Evangelista, principal, Deloitte Consulting LLP
Without committed leadership from the top of an organization, the best answers will not find the light of day, and the “my number is better than yours” issue will persist. The shackles of the past (standard reports with standard data) will inevitably bind companies to increasingly [...]
Posted in Guest Blog, Webcast, leadership Also tagged business, Competitive advantage, Consulting, Deloitte, Management, Management science, Marketing, Webcast Leave a comment
Pfizer Settles Whistleblower Case for $2.3 Billion
Image by Getty Images via Daylife
Pfizer, on Wednesday, agreed to pay $2.3 billion to end a US Department of Justice investigation citing the company for illegal off-label marketing tactics related to a number of products. It represents the largest single settlement of its type for a pharmaceutical company, topping Lilly’s $1.4 billion Zyprexa settlement reached [...]
Pharma Industry Booming in Eastern Europe
Eastern Europe’s pharmaceutical market is forecast to grow at a CAGR of more than 10 percent to be worth more than $41 billion by 2014, according to a report from globalbusinessinsights.com. The highest sales are expected to be seen in the cardiovascular market ($7.8 billion), followed by alimentary canal and metabolic disorders ($6 billion).
According to [...]
Posted in Global Also tagged business, Czech Republic, Eastern Europe, Novartis, Pharmaceutical drug, Sanofi-Aventis, Slovenia 1 Comment

PhRMA’s Tauzin Calls it a Day